DENTSPLY SIRONA Inc. (XRAY) vs Zenas BioPharma, Inc. (ZBIO)
A side-by-side comparison of DENTSPLY SIRONA Inc. and Zenas BioPharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
XRAY
DENTSPLY SIRONA Inc.
$8.52HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ZBIO
Zenas BioPharma, Inc.
$26.94HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — XRAY vs ZBIO
growth of $100 · dividends reinvested · last 2yXRAY -64.1% (-40.1%/yr)ZBIO +54.9% (+24.4%/yr)ZBIO compounded faster over this window
XRAY ZBIO
XRAY vs ZBIO: by the numbers
- •XRAY is the larger company ($1.71B vs $1.70B market cap).
- •Both run net losses; XRAY's is the smaller (-14.99% vs -48438.40% net margin).
- •XRAY pays a dividend (3.74% yield), while ZBIO has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | XRAY | ZBIO |
|---|---|---|
| Forward P/E | 5.59 | N/A |
| P/S ratio | 0.47 | 1700.81 |
| P/B ratio | 1.26 | 6.88 |
| EV / EBITDA | 4.43 | N/A |
| FCF yield | 8.38% | N/A |
Profitability
| Metric | XRAY | ZBIO |
|---|---|---|
| Gross margin | 49.52% | 100.00% |
| Operating margin | 11.69% | -2113.85% |
| Net margin | -14.99% | -48438.40% |
| ROE | -40.41% | -196.03% |
| ROIC | 10.03% | -74.69% |
Dividends
| Metric | XRAY | ZBIO |
|---|---|---|
| Dividend yield | 3.74% | N/A |
Growth (annualized)
| Metric | XRAY | ZBIO |
|---|---|---|
| Revenue CAGR (5Y) | 1.96% | N/A |
| FCF CAGR (5Y) | -25.74% | N/A |
| Total return CAGR (5Y) | -30.27% | N/A |
Frequently asked
- Does XRAY or ZBIO pay a bigger dividend?
- XRAY pays a dividend (3.74% yield), while ZBIO has no payments in the available dividend history.
Go deeper
Dig into the metrics
DENTSPLY SIRONA dividend yieldDENTSPLY SIRONA ROEZenas BioPharma ROEDENTSPLY SIRONA operating marginZenas BioPharma operating marginDENTSPLY SIRONA revenue growthZenas BioPharma revenue growthDENTSPLY SIRONA free cash flowZenas BioPharma free cash flow
DENTSPLY SIRONA & Zenas BioPharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.